missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ezrin Monoclonal Antibody (3C12), Invitrogen™
Mouse Monoclonal Antibody
Brand: Invitrogen MA513862
This item is not returnable.
View return policy
Description
MA5-13862 targets Ezrin in IHC (P), ICC, IP, IF, and WB applications and shows reactivity with Bovine, Hamster, Human, Marsupial, mouse, Non-human primate, and Rat samples. The MA5-13862 immunogen is a recombinant fragment of human ezrin corresponding to aa 362-585.
The cytoplasmic peripheral membrane protein encoded by this gene functions as a protein-tyrosine kinase substrate in microvilli. As a member of the ERM protein family, this protein serves as an intermediate between the plasma membrane and the actin cytoskeleton. This protein plays a key role in cell surface structure adhesion, migration and organization, and it has been implicated in various human cancers. A pseudogene located on chromosome 3 has been identified for this gene. Alternatively spliced variants have also been described for this gene.Specifications
Ezrin | |
Monoclonal | |
0.2 mg/mL | |
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
P15311, P26040, P31976, P31977 | |
Ezr | |
A recombinant fragment of human ezrin corresponding to aa 362-585 | |
500 μL | |
Primary | |
Bovine, Hamster, Human, Marsupial, Mouse, Non-human Primate, Rat | |
Antibody | |
IgG1 |
Immunocytochemistry, Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot | |
3C12 | |
Unconjugated | |
Ezr | |
AW146364; CVIL; CVL; Cytovillin; cytovillin 2; DKFZp762H157; epididymis secretory protein Li 105; ezr; ezr.L; ezr.S; EZRI; Ezrin; ezrin L homeolog; ezrin L homeolog; ezrin S homeolog; FLJ26216; HEL-S-105; MGC1584; p81; R75297; VIL2; villin 2; villin 2 (ezrin); villin-2; XELAEV_18027043mg | |
Mouse | |
Protein G | |
RUO | |
100762541, 22350, 281574, 54319, 7430 | |
4° C | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction